Correction to “Hypoxia‐Elicited Mesenchymal Stem Cell‐Derived Small Extracellular Vesicles Alleviate Myocardial Infarction by Promoting Angiogenesis through the miR‐214/Sufu Pathway”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsExtracellular vesicles in disease · Cardiovascular Disease and Adiposity · Mesenchymal stem cell research
L. Shao, Y. Chen, J. Li, et al., “Hypoxia‐Elicited Mesenchymal Stem Cell‐Derived Small Extracellular Vesicles Alleviate Myocardial Infarction by Promoting Angiogenesis through the miR‐214/Sufu Pathway,” Stem Cells International 2023 (2023): 1662182, https://doi.org/10.1155/2023/1662182.
In the article titled “Hypoxia‐Elicited Mesenchymal Stem Cell‐Derived Small Extracellular Vesicles Alleviate Myocardial Infarction by Promoting Angiogenesis through the miR‐214/Sufu Pathway,” the panels b, c, d, and e of Figure 1 were labeled incorrectly.
More specifically:
“[MSC‐Exos]” should read “[MSC‐sEVs]”
and
“[MSChyp‐Exos]” should read “[MSChyp‐sEVs].”
The corrected Figure 1 is shown below:
We apologize for this error.